PS.
PublicSupply
account_balanceBuyersbusinessSuppliersdescriptionNoticescategoryCategories
BuyersSuppliersNoticesCategories
verified_userData sourced from Contracts Finder, Find a Tender, and Companies House.
Contracts Finder ↗Find a Tender ↗Procurement Act 2023 ↗
  1. Home›
  2. Suppliers›
  3. Norgine Pharmaceuticals Limited
NP

Norgine Pharmaceuticals Limited

Uxbridge
Large
norgine.com ↗
Compare peers
Awarded
£560.8m
Live
17
Buyers
6
12m
£529.1m
At a glance
  • Quick answer
Profile
  • Social value
  • ESG & policies
  • Capabilities3
  • Buyer references
  • Accreditations
Track record · verified
  • KPI performance
  • Contracts17 / 23
  • Top buyers6
  • Category mix
  • Geography
  • Peers5
Trust & risk
  • Red flags0
  • Compliance
  • Modifications
  • News
Company
  • Companies House
  • Financial
  • Org tree
Quick answer — Norgine Pharmaceuticals LimitedUpdated 13 Jul 2026

At a glance · for buyers and watchdogs

Norgine Pharmaceuticals Limited has won £560.8m across 6 public-sector buyers, with 17 live contracts. No active Companies House risk flags.

Why: top buyer NHS England at 100% · 0 active risk flags · 0 modifications.

Decision signals
0Active red flags
ActiveCompany status
17 of 23Live contracts
100%Top-buyer concentration
—Category exposure
0Contract modifications
If you're a buyer:CapabilitiesReferencesKPIComplianceWatchdog?FlagsModificationsConcentrationNews

Social value

Commitments mapped to the Government Social Value Model themes.

⚑ Self-reported
—

No social-value commitments yet

Jobs, skills, environmental, inequality and community commitments appear here once a claimed supplier attributes them to awarded contracts, or once we detect them on the supplier’s website.

ESG & policies vault · 0/5

Key governance & sustainability policies. Published documents link out; missing ones are greyed.

↔ Cross-checked
Net-zero planNot provided✓
Modern slavery statementNot provided✓
EDI policyNot provided✓
Anti-briberyNot provided✓
Data protectionNot provided✓

Capabilities

What this supplier does, where they sit, who they sell to.

⚑ Self-reported & from notices

Service tags, sectors served and target geographies appear here once a supplier verifies ownership of this profile.

Frameworks & DPS · 3 from notices
  • NHS Framework Agreement for Branded medicines - NationalNHS England · £6.1m
  • NHS National Pharmaceuticals Transition 2022_1NHS England and NHS Improvement · £944k
  • Cardiac Surgery, Cardiac Rhythm Management, Diagnostic and Interventional Consumables and Associated ProductsNHS Supply Chain : NHS Supply Chain · —

Case studies

Delivery stories the supplier has published, with sector and outcome.

⚑ Self-reported
—

No case studies yet

Once a claimed supplier publishes delivery stories — the buyer, the sector, what was delivered and the outcome — they appear here.

Buyer references

Named public-sector contacts who have agreed to act as a reference.

✓ Confirmed by buyer
—

No buyer references yet

Public-sector buyers can confirm they'll act as a reference for this supplier. Confirmed references — with the contract they relate to — show here.

Accreditations & memberships

Independently issued. Verification dates cross-checked against issuer registers.

↔ Cross-checked
—

No accreditations recorded

B-Corp, ISO, Cyber Essentials, Living Wage and similar credentials appear here once added by a claimed supplier and cross-checked against the issuing register.

KPI performance

Delivery, budget and satisfaction scores reported quarterly by buyers.

✓ Verified
84

No verified KPI scores yet

Once buyers report contract KPIs — delivery on time, on budget, satisfaction, adoption and accessibility — a weighted grade and breakdown appear here.

Contracts · 17 live · 6 historic

Pulled from Contracts Finder & Find a Tender. Most recent first.

✓ From notices
TitleBuyerCPVAwardedValueTermStatus
NHS National Branded Interim - 1 June 2026
NHS England—01 Jun 2026£529.1m1.9 yrspending
NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 2)
NHS England3360000001 Jun 2024£0.023 yrsLive
NHS Framework Agreement-Branded Medicines - National Proprietary Pharmaceuticals
NHS England3360000001 May 2023£6.1m2 yrsClosed
NHS National Pharmaceuticals Transition 2022_1
NHS England and NHS Improvement3360000029 Jul 2022£944k1.8 yrsClosed
NHS Framework Agreement for Branded medicines - National
NHS England3360000001 May 2022£6.1m2 yrsClosed
NHS Framework Agreement for Branded Medicines - National
NHS England3360000001 May 2019£18.5m2 yrsClosed
Cardiac Surgery, Cardiac Rhythm Management, Diagnostic and Interventional Consumables and Associated Products
NHS Supply Chain : NHS Supply Chain3300000001 Feb 2017—4 yrsClosed
NHS National Branded Interim - 1 June 2026
NHS England————Live
NP39823 Gastro Intestinal, Endocrine, Nutrition & Blood Medicine
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)33600000———Live
NHS National Generic Pharmaceuticals Wave 14b
NHS England33600000———Live
Total live value £0.02 · mean award £24.4m1–10 of 23

Top buyers · 6 buyers · top 3 = 100%

Share of awarded value. Concentration fires above 40% for any single buyer.

✓ From notices
1
NHS England
13 contracts
100%
since 2019
2
NHS England and NHS Improvement
1 contract
0%
since 2022
3
NHS Supply Chain : NHS Supply Chain
1 contract
0%
since 2017
4
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
4 contracts
0%
5
Velindre NHS Trust, NHS Shared Services Partnership - Procurement Services (on behalf of All Wales Health Boards and Trusts)
3 contracts
0%
6
The NHS Commissioning Board (operating under the name of NHS England)
1 contract
0%

Geography

Distribution of awarded value by buyer region.

✓ From notices
UK · schematic only
Yorkshire14 contracts
100%
Scotland4 contracts
0%
Wales3 contracts
0%
North West1 contract
0%

Peers

Suppliers with overlapping CPVs & buyers (last 24m). Norgine Pharmaceuticals Limited highlighted.

✓ From notices
SupplierSME?Awarded · 24mContracts
NP
Norgine Pharmaceuticals Limited
No£529.1m—
MA
Medequip Assistive Technology Ltd
No£82.0m2
AH
Alcura Healthcare Ltd.
No£18.7m1
IP
ITH Pharma Ltd
Yes£3.0m4
QL
Qualasept Ltd t/a Bath ASU
Yes£3.0m2
BH
BAXTER HEALTHCARE LIMITED
Yes£3.0m1
Compare peers →

Red flags · 0 active

Automated scan of Companies House status, charges and insolvency records.

✓ Verified
✓ Clean. No active risk signals from Companies House status, charges or insolvency records.

Compliance scorecard

Derived from Companies House filings — not a full supplier-assurance check.

↔ Cross-checked
Trading status
Active
Live at Companies House
Annual accounts
Up to date
Last made up to 31 Dec 2024
Confirmation statement
Up to date
Next due 27 Mar 2027
Outstanding charges
0
No charges registered
Insolvency history
None
No insolvency cases registered
Certifications (ISO, Cyber Essentials, Living Wage, B-Corp, modern-slavery) are supplier self-reported and appear once a claimed profile adds them.

Modifications

Variations to awarded contracts logged under Procurement Act 2023 s.74.

✓ From notices
±

No modifications recorded

No published contract variations for this supplier. Modification notices appear here as they are issued under the Procurement Act 2023.

News mentions

UK trade press & nationals, matched to this supplier.

◰

No news mentions found

We haven't matched any recent UK press coverage to this supplier. Mentions appear here automatically as they're published.

Companies House

Live sync — registered details, directors, PSC and SIC codes.

✓ Live sync

Registered details

Company no.
03527131
Status
Active
Type
Private limited
Incorporated
13 Mar 1998
Reg. office
Arc Uxbridge Building 01, Sanderson Road, Uxbridge, UB8 1DH
SIC codes
46460
Last accounts
31 Dec 2024
Next accounts due
30 Sept 2026

Directors & PSC

  • VAN DER KAMP, Hilde Johanna — director
    Appointed 04 Mar 2026
  • ACKLAND, Katharine Grace — director
    Appointed 04 Jul 2025
  • BARRETO MARTINIANO, Saulo — director
    Appointed 31 Dec 2023
  • ASHTON, Mark Steven — director
    Appointed 12 Sept 2022
  • Spinnaker Debtco Limited — person with significant control
    ownership of shares 75 to 100 percent · voting rights 75 to 100 percent · right to appoint and remove directors

Financial

Filed accounts from Companies House.

↔ From Cos House
£

No financial filings on record

Turnover, profit and headcount appear here once audited or micro-entity accounts are filed at Companies House.

Org tree

Group structure and ownership.

↔ From Cos House
NORGINE PHARMACEUTICALS LIMITED
03527131 · this company

Independent. No parent company or subsidiaries recorded at Companies House for this entity.